n,n-dimethylarginine has been researched along with Gastric Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brzozowski, T; Jasnos, K; Krzysiek-Maczka, G; Kwiecien, S; Magierowski, M; Ptak-Belowska, A; Sliwowski, Z; Surmiak, M | 1 |
| Jiang, DJ; Li, YJ; Peng, J; Wang, L; Zhang, Z; Zhou, Y | 1 |
2 other study(ies) available for n,n-dimethylarginine and Gastric Diseases
| Article | Year |
|---|---|
Exogenous asymmetric dimethylarginine (ADMA) in pathogenesis of ischemia-reperfusion-induced gastric lesions: interaction with protective nitric oxide (NO) and calcitonin gene-related peptide (CGRP).
Topics: Animals; Arginine; Blood Flow Velocity; Calcitonin Gene-Related Peptide; Capsaicin; Drug Interactions; Enzyme-Linked Immunosorbent Assay; Gastric Mucosa; Interleukin-10; Isoxazoles; Male; Malondialdehyde; Nitric Oxide; Rats, Wistar; Reperfusion Injury; Stomach Diseases; Tumor Necrosis Factor-alpha | 2014 |
Role of endogenous nitric oxide synthase inhibitor in gastric mucosal injury.
Topics: Amidohydrolases; Animals; Arginine; Campylobacter jejuni; Cell Line; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epithelial Cells; Ethanol; Gastric Acid; Gastric Mucosa; Helicobacter pylori; Humans; Indomethacin; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Stomach Diseases; Tumor Necrosis Factor-alpha | 2008 |